Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 1
2003 1
2004 4
2005 1
2006 5
2007 2
2008 9
2009 6
2010 9
2011 9
2012 16
2013 15
2014 23
2015 35
2016 22
2017 31
2018 32
2019 35
2020 43
2021 64
2022 81
2023 79
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

476 results

Results by year

Filters applied: . Clear all
Page 1
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
Wang Y, Tong Q, Ma SR, Zhao ZX, Pan LB, Cong L, Han P, Peng R, Yu H, Lin Y, Gao TL, Shou JW, Li XY, Zhang XF, Zhang ZW, Fu J, Wen BY, Yu JB, Cao X, Jiang JD. Wang Y, et al. Among authors: cong l. Signal Transduct Target Ther. 2021 Feb 24;6(1):77. doi: 10.1038/s41392-020-00456-5. Signal Transduct Target Ther. 2021. PMID: 33623004 Free PMC article.
Anosmia, mild cognitive impairment, and biomarkers of brain aging in older adults.
Dong Y, Li Y, Liu K, Han X, Liu R, Ren Y, Cong L, Zhang Q, Hou T, Song L, Tang S, Shi L, Luo Y, Kalpouzos G, Laukka EJ, Winblad B, Wang Y, Du Y, Qiu C. Dong Y, et al. Among authors: cong l. Alzheimers Dement. 2023 Feb;19(2):589-601. doi: 10.1002/alz.12777. Epub 2022 Sep 15. Alzheimers Dement. 2023. PMID: 36341691
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia.
Xiao S, Chan P, Wang T, Hong Z, Wang S, Kuang W, He J, Pan X, Zhou Y, Ji Y, Wang L, Cheng Y, Peng Y, Ye Q, Wang X, Wu Y, Qu Q, Chen S, Li S, Chen W, Xu J, Peng D, Zhao Z, Li Y, Zhang J, Du Y, Chen W, Fan D, Yan Y, Liu X, Zhang W, Luo B, Wu W, Shen L, Liu C, Mao P, Wang Q, Zhao Q, Guo Q, Zhou Y, Li Y, Jiang L, Ren W, Ouyang Y, Wang Y, Liu S, Jia J, Zhang N, Liu Z, He R, Feng T, Lu W, Tang H, Gao P, Zhang Y, Chen L, Wang L, Yin Y, Xu Q, Xiao J, Cong L, Cheng X, Zhang H, Gao D, Xia M, Lian T, Peng G, Zhang X, Jiao B, Hu H, Chen X, Guan Y, Cui R, Huang Q, Xin X, Chen H, Ding Y, Zhang J, Feng T, Cantillon M, Chen K, Cummings JL, Ding J, Geng M, Zhang Z. Xiao S, et al. Among authors: cong l. Alzheimers Res Ther. 2021 Mar 17;13(1):62. doi: 10.1186/s13195-021-00795-7. Alzheimers Res Ther. 2021. PMID: 33731209 Free PMC article. Clinical Trial.
TLR4 biased small molecule modulators.
Lin C, Wang H, Zhang M, Mustafa S, Wang Y, Li H, Yin H, Hutchinson MR, Wang X. Lin C, et al. Pharmacol Ther. 2021 Dec;228:107918. doi: 10.1016/j.pharmthera.2021.107918. Epub 2021 Jun 23. Pharmacol Ther. 2021. PMID: 34171331 Review.
Role of NLRP3 inflammasome in systemic sclerosis.
Lin C, Jiang Z, Cao L, Zou H, Zhu X. Lin C, et al. Arthritis Res Ther. 2022 Aug 16;24(1):196. doi: 10.1186/s13075-022-02889-5. Arthritis Res Ther. 2022. PMID: 35974386 Free PMC article. Review.
476 results